Literature DB >> 28825379

Oncostatin M and TNF-α Induce Alpha-1 Antitrypsin Production in Undifferentiated Adipose Stromal Cells.

Kevin Ni1,2, Muhammad Umair Mukhtar Mian2, Catherine Meador2, Amar Gill1, Daria Barwinska2, Danting Cao1, Matthew J Justice1,3, Di Jiang1, Niccolette Schaefer1, Kelly S Schweitzer1,2, Hong Wei Chu1, Keith L March2,4, Irina Petrache1,2,3.   

Abstract

Alpha-1 antitrypsin (A1AT), a circulating acute-phase reactant antiprotease, is produced and secreted by cells of endodermal epithelial origin, primarily hepatocytes, and by immune cells. Deficiency of A1AT is associated with increased risk of excessive lung inflammation and injury, especially following chronic cigarette smoke (CS) exposure. Exogenous administration of mesenchymal progenitor cells, including adipose tissue-derived stromal/stem cells (ASC), alleviates CS-induced lung injury through paracrine effectors such as growth factors. It is unknown, however, if mesodermal ASC can secrete functional A1AT and if CS exposure affects their A1AT production. Human ASC collected via liposuction from nonsmoking or smoking donors were stimulated by inflammatory cytokines tumor necrosis alpha (TNFα), oncostatin M (OSM), and/or dexamethasone (DEX) or were exposed to sublethal concentrations of ambient air control or CS extract (0.5%-2%). We detected minimal expression and secretion of A1AT by cultured ASC during unstimulated conditions, which significantly increased following stimulation with TNFα or OSM. Furthermore, TNFα and OSM synergistically enhanced A1AT expression and secretion, which were further increased by DEX. The A1AT transcript variant produced by stimulated ASC resembled that produced by bronchial epithelial cells rather than the variant produced by monocytes/macrophages. While the cigarette smoking status of the ASC donor had no measurable effect on the ability of ASC to induce A1AT expression, active exposure to CS extract markedly reduced A1AT expression and secretion by cultured ASC, as well as human tracheobronchial epithelial cells. ASC-secreted A1AT covalently complexed with neutrophil elastase in control ASC, but not in cells transfected with A1AT siRNA. Undifferentiated ASC may require priming to secrete functional A1AT, a potent antiprotease that may be relevant to stem cell therapeutic effects.

Entities:  

Keywords:  alpha-1-proteinase inhibitor; cigarette smoke; human adipose progenitor cell

Mesh:

Substances:

Year:  2017        PMID: 28825379      PMCID: PMC5651966          DOI: 10.1089/scd.2017.0099

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  51 in total

1.  Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells.

Authors:  J Cichy; J Potempa; J Travis
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

2.  Oncostatin M production by blood and alveolar neutrophils during acute lung injury.

Authors:  A Grenier; D Combaux; J Chastre; M A Gougerot-Pocidalo; C Gibert; M Dehoux; S Chollet-Martin
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

3.  N-terminal amino acid sequences of precursor and mature forms of alpha-1-antitrypsin.

Authors:  V Gross; C Kaiser; T A Tran-Thi; E Schmelzer; I Witt; T H Plummer; P C Heinrich
Journal:  FEBS Lett       Date:  1983-01-24       Impact factor: 4.124

4.  Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.

Authors:  Hong Li; Bin Zhang; Yuanqing Lu; Marda Jorgensen; Bryon Petersen; Sihong Song
Journal:  J Hepatol       Date:  2010-11-03       Impact factor: 25.083

5.  Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation.

Authors:  Betty T Tran; Abigail Halperin; Jason W Chien
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-29       Impact factor: 5.742

6.  alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis.

Authors:  Irina Petrache; Iwona Fijalkowska; Terry R Medler; Jarrett Skirball; Pedro Cruz; Lijie Zhen; Horia I Petrache; Terence R Flotte; Rubin M Tuder
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

Authors:  Jalees Rehman; Dmitry Traktuev; Jingling Li; Stephanie Merfeld-Clauss; Constance J Temm-Grove; Jason E Bovenkerk; Carrie L Pell; Brian H Johnstone; Robert V Considine; Keith L March
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

8.  Hepatic differentiation potential of commercially available human mesenchymal stem cells.

Authors:  Shin-Yeu Ong; Hui Dai; Kam W Leong
Journal:  Tissue Eng       Date:  2006-12

9.  Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis.

Authors:  Hongyan Lu; Christophe Poirier; Todd Cook; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Benjamin Lease; Irina Petrache; Keith L March; Natalia V Bogatcheva
Journal:  J Transl Med       Date:  2015-02-21       Impact factor: 5.531

10.  Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells.

Authors:  Trivia P Frazier; Jeffrey M Gimble; Jessica W Devay; Hugh A Tucker; Ernest S Chiu; Brian G Rowan
Journal:  BMC Cell Biol       Date:  2013-08-07       Impact factor: 4.241

View more
  2 in total

1.  Rapid clearance of heavy chain-modified hyaluronan during resolving acute lung injury.

Authors:  Kevin Ni; Amar Gill; Victor Tseng; Andrew M Mikosz; Kengo Koike; Erica L Beatman; Cassie Y Xu; Danting Cao; Fabienne Gally; Kara J Mould; Karina A Serban; Kelly S Schweitzer; Keith L March; William J Janssen; Eva Nozik-Grayck; Stavros Garantziotis; Irina Petrache
Journal:  Respir Res       Date:  2018-05-31

2.  Alpha-1 Antitrypsin Induces Epithelial-to-Mesenchymal Transition, Endothelial-to-Mesenchymal Transition, and Drug Resistance in Lung Cancer Cells.

Authors:  Dong-Ming Wu; Teng Liu; Shi-Hua Deng; Rong Han; Ting Zhang; Jing Li; Ying Xu
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.